, with an effect size much smaller than that observed in the replication analysis of a previous in silico GWAS.
In a hypothesis-generating GWAS, we confirm an association between TFAM and mtDNA CN, and present putative loci requiring replication in much larger samples. We discuss the limitations of our work, in terms of measurement error and cellular heterogeneity, and highlight the need for larger studies to better understand nuclear genomic control of mtDNA copy number.
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Mitochondria are the cellular organelles responsible for producing adenosine triphosphate (ATP), a ubiquitous substrate required for metabolism. ATP is the final product of the series of redox reactions that are facilitated by the complexes of the respiratory chain (RC), located on the cristae, the folded inner membrane of mitochondria.
Mitochondria possess their own genome (mtDNA), an extra-nuclear, double-stranded, circular DNA molecule of ~16.6kb that is inherited maternally. Thirteen subunits contributing to complexes of the RC are encoded by mtDNA, and the entire mitochondrial genome is present at variable copy number in the cell. The relative copy number of mtDNA (mtDNA CN) may reflect differing energy requirements between cells: those from active tissues (e.g. liver, muscle, neuron) are observed to have higher mtDNA CNs compared to endothelial cells, which are comparatively quiescent. (Moyes et al. 1998; Xing et al. 2008; Dickinson et al. 2013) Several nuclear genes are known to influence the regulation of mtDNA CN, and these are reviewed in detail elsewhere. (Rotig and Poulton 2009; Carling et al. 2011; Harvey et al. 2011; Dickinson et al. 2013 ) These include POLG (Oskoui et al. 2006; Bornstein et al. 2008; Rotig and Poulton 2009; Spinazzola et al. 2009; Tyynismaa et al. 2009; Carling et al. 2011; Chiaratti et al. 2011; Harvey et al. 2011; Venegas et al. 2011 ) and POLG2, (Tyynismaa et al. 2009; Carling et al. 2011; Harvey et al. 2011 ) the catalytic and accessory subunits of DNA polymerase-gamma, the principal enzyme implicated in mtDNA replication. Other regulators include TFAM (mitochondrial transcription factor A), (Choi et al. 2006; Belin et al. 2007; Curran et al. 2007; Alvarez et al. 2008; Carling et al. 2011; Cai et al. 2015) which initiates mtDNA replication, along with other factors TFB1M and TFB2M. (Carling et al. 2011; Chiaratti et al. 2011; Grady et al. 2014 ) Regulators of these transcription factors include PGC-1α
(peroxisome proliferators-activated receptor gamma coactivator 1 alpha) (Carling et al. 2011; Chiaratti et al. 2011; Harvey et al. 2011 ) and two nuclear respiratory factors (NRF-1, NRF-2). (Carling et al. 2011; Chiaratti et al. 2011; Harvey et al. 2011 (Bornstein et al. 2008; Rotig and Poulton 2009; Spinazzola et al. 2009; Tyynismaa et al. 2009; Carling et al. 2011; Chiaratti et al. 2011; Harvey et al. 2011; Venegas et al. 2011 ) along with thymidine phosphorylase (TYMP) (Bornstein et al. 2008; Carling et al. 2011; Harvey et al. 2011 ) and the target of the p53-transcription factor, p53R2 (encoded by RRM2B). (Bornstein et al. 2008; Rotig and Poulton 2009; Tyynismaa et al. 2009; Carling et al. 2011; Venegas et al. 2011) The role of succinyl CoA synthase deficiency as a cause of mtDNA depletion is less well understood, but mutations in the alpha and β subunits of Succinyl CoA synthase genes (SUCLA2, SUCGL1), (Bornstein et al. 2008; Rotig and Poulton 2009; Spinazzola et al. 2009; Venegas et al. 2011 ) may be associated with mitochondrial nucleotide depletion. (Rotig and Poulton 2009) To our knowledge, few genome-wide scans of mtDNA CN have been published, and those that exist are of relatively small sample size, (Curran et al. 2007; López et al. 2014; Workalemahu et al. 2017) or use in silico proxies for mtDNA CN without actual biological measurements. (Cai et al. 2015) We had access to directly assayed mtDNA CN in a diverse set of study groups, and so performed hypothesis-generating genome-wide association studies (GWAS) in ~14,000 individuals participants from the Avon Longitudinal Study of Parents and Children (ALSPAC) and the UK Blood Service (UKBS) cohort. For our main analyses, the two most comparable study groups of adult females were combined in a joint analysis (N = 6799, approximately 10-times larger than previous GWASs of directly assayed mtDNA CN), (López et al. 2014; Workalemahu et al. 2017) with results from the other groups presented as opportunistic, secondary analyses. It is known that cellular heterogeneity contributes to mtDNA CN: granulocytes have relatively few mitochondria, whereas lymphocytes are rich in mitochondria, and therefore in mtDNA. (Pyle et al. 2010) Since we also had access to data on white cell proportions, estimated from methylation data in ALSPAC, and assayed directly in UKBS, we performed sensitivity analyses that considered DNA source (whole blood/white cells), and controlled for white cell proportions. Finally, we extracted two SNPs that were robustly related to mtDNA CN in a recent GWAS of mtDNA CN measured in silico, (Cai et al. 2015 ) and compared our results to those published associations. r  t  i  c  i  p  a  n  t  s  a  n  d  M  e  t  h  o  d  s   C  o  h  o  r  t  d  e  t  a  i  l  s ALSPAC is a prospective cohort of mothers and their children. Between 1991 Between -1992 women living in the former county of Avon, UK, were recruited during pregnancy, of whom 13,761 were enrolled into the study (women were aged between 16-43 years at recruitment, when samples for mtDNA CN analyses were obtained). Further details are available in the cohort profile papers, (Fraser et al. 2013; Boyd et al. 2013) year olds, ALSPAC mothers' DNA was extracted from whole blood or white cells, and ALSPAC neonates had DNA extracted from white cells, as described previously.(Jones et al.
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UKBS blood samples were separated by density centrifugation, and white blood cells were retained to perform DNA extractions, as previously described, using a guanidine-chloroformbased method. (Burton et al. 2007; Nalls et al. 2011 Further details of genotype QC are given in Appendix 1.
GWAS were run separately in 5,461 ALSPAC mothers, 3,647 6-9 year olds, and 2,102
neonates (see Appendix 2 for details of selection into the study). Relatedness within each group of participants (mothers, neonates and 6-9 year olds) was assessed by identical-bydescent (IBD) proportions from a genetic-relatedness matrix, calculated using the GCTA standard algorithm, (Yang et al. 2011 M a i n a n a l y s e s We had access to several study groups with relevant data. Since these groups were diverse in nature, and were of relatively small sample sizes (compared to some complex trait GWAS), we did not consider them as 'discovery' and 'replication' cohorts. Instead, after validating and harmonising data (see 'Assay of mtDNA CN'), we considered our main analyses to be hypothesis-generating GWAS of the two most comparable groups, i.e. all adult females (5461 ALSPAC mothers and 1338 UKBS females). This decision also took into account results from some preliminary analyses that suggested some possible differences between UKBS females and males (see Supplementary Figures 3 and 4) , although we acknowledge that we have insufficient power to detect sex differences that are not potentially due to chance.
Thus, results from ALSPAC mothers and UKBS females were meta-analysed, using random-effects models ('Meta-analysis 1'). Since ALSPAC mothers had DNA extracted from two sources, a sensitivity meta-analysis ('Meta-analysis 2', N=4,743) restricted the ALSPAC mothers to 3,405 females with white cell DNA extracted by a phenol-chloroform method (i.e. the most comparable subgroup to UKBS females, all of whom had white cell DNA extracted by a guanidine-chloroform based method (Burton et al. 2007; Nalls et al. 2011) ).
Heterogeneity was assessed using Cochran's Q statistic, (Cochran 1954) 1333 UKBS males are presented as secondary analyses. We applied the same p-value threshold for genome-wide significance, and also specifically looked at whether hits identified in these groups showed similar directions and magnitudes of association in the meta-analyses of adult females. However, we did not consider these groups to be suitable replication samples for the main analyses of adult females, given their small sample sizes, and sex and age differences.
A recent large GWAS (using a discovery sample of 10,560 Han Chinese females) identified TFAM (mitochondrial transcription factor A) and CDK6 (Cyclin Dependent Kinase 6), as loci strongly associated with mtDNA CN estimated in silico, from sequence data. (Cai et al. 2015) The replication sample for that study included 1,753 ALSPAC children within the UK10K consortium. (Walter et al. 2015) There is overlap between that group, and the 6-9 year olds studied in the current analysis. (Cai et al. 2015) Using all available unrelated participants in the current study (i.e. excluding mother-child duos, N=11,253 total), we meta-analysed the two lead SNPs at these loci, and compared our results to those of this previous GWAS. (Cai et al. 2015 Results from the main meta-analysis of adult females (N=6799, 'Meta-analysis 1'), as well as the analysis restricted to those with white cell-extracted DNA (N=4743, 'Meta-analysis 2') are given in Table 2 . SNPs in associated regions were clustered into 1Mb windows. (Quinlan and Hall 2010) For each analysis, results are shown before and after cell-proportion adjustment.
Annotations are given for loci within 200kb. (Eberle et al. 2006) Coordinates are hg19.
Meta-analysis 1: all adult females (N=6799)
No SNP passed the genome-wide significance threshold of p<5e -08 . The top panel of Table 2 describes two top loci (p<1e-06) identified from the main meta-analysis of all adult females:
these included an intergenic locus on chr13 (lead SNP rs12873707, . A list of all SNPs associated at p<1e-06 in these loci is given in Supplementary   Table 6 . (Table 3) . Despite differences in the proportion of participants with information that enabled adjustment for cell-type, there was consistency across study groups with each showing an approximate 50% attenuation of the effect size with adjustment for cell proportions.
Regional association plots (see Panels A and B of
Meta-analysis 2: adult females with white cell-extracted DNA (N=4743)
The bottom panel of Table 2 gives details of the strongest association in the meta-analysis restricted to ALSPAC mothers with DNA extracted from white cells ('Meta-analysis 2'). The locus associated with mtDNA CN (p<1e -06 ) was rs150387260, an intergenic variant (β [SE] 0.405 [0.084], p=1.65e-06, I 2 =0, see also Supplementary Table 7 ). 
Effect of adjusting for cell-proportions in these two meta-analyses
In Meta-analysis 1 (all adult females, regardless of DNA source), point estimates attenuated after cell proportion adjustment, although the reduced sample size meant that confidence intervals were wide. In contrast, after cell proportion adjustment for the association identified from Meta-analysis 2 (restricted to females with white cell-extracted DNA), confidence intervals were also wide, but the effect estimate was not attenuated (it increased slightly). The top panel shows hits p<1e-06 from the meta-analysis of all ALSPAC Mothers (N=5461) and UKBS Females (N=1338): 'Meta-analysis 1'. The lower panel shows a meta-analysis restricted to females with DNA extracted from white cells (3405 ALSPAC mothers, 1338 UKBS females). In Meta-analysis 2, there were no associations at p<1e-06, so instead the next strongest association is shown. Abbreviations: rsID=SNP identifier; chr:pos_nonEA_EA=chromosome, position, non-effect allele, effect allele; β =regression coefficient (additive model); SE=standard error; P=p-value; Q=Cochran's Q statistic; bp=base pairs; P (het)= p-value for heterogeneity; I 2 -statistic for heterogeneity; P (ALSP)=p-value in ALSPAC analysis contributing to meta-analysis (N=5461 or N=3405); P (UKBSF)=p-value in UKBS females analysis; P (CC)=P (cell-proportion adjusted version of meta-analysis). a NB large drop in number of ALSPAC mothers after cell-proportion adjustment (See Table 1 ). Figure 7 . A list of all SNPs at p<1e-06 in the 6-9 year olds is available in Figure 8 . A list of SNPs associated with mtDNA CN at p<1e-06 in neonates is available in Figure 3 . A list of SNPs at p<1e-06 in UKBS males is available in Supplementary Table 10 .
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The results of a look-up of two loci (rs11006126 and rs445) that are strongly associated with mtDNA CN measured in silico (Cai et al. 2015) are presented in Figure 4 . Estimates for these SNPs were extracted from, and meta-analysed across all study groups (after removing ALSPAC mother-offspring pairs; total N for these meta-analyses = 11253, see also 'Genotype data'). rs11006126 was associated with mtDNA CN across our study groups (β [SE] 0.046 [0.017], p=0.007, but the effect size was considerably (~1/7 of the size) smaller than that observed in the discovery and replication cohorts of the in silico GWAS. There was no evidence of replication of rs445 across our study groups (β [SE] 0.021 [0.022], p=0.328) compared with discovery and replication result from the in silico GWAS. β =regression coefficient (additive model); SE=standard error; P=p-value; P (Proxy)=p-value (for a proxy SNP, rs144928561, r 2 =0.29); P (CC)=p-value (cellproportion adjusted analysis); P (MA1)=p-value ('Meta-analysis 1', 6799 adult females); p-value (MA2)=P ('Meta-analysis 2', 4743 females with DNA from white cells). a NB large drop in power for ALSPAC mothers (See Table 1 ).
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We conducted the largest ever GWAS of directly assayed mtDNA CN, in two populationbased cohorts. Although diversity between our study groups prevented us from conceptualising a traditional discovery and replication model, we considered our study as hypothesis generating, and meta-analysed the two most comparable groups (ALSPAC mothers and UKBS females) as our main analyses, and other subgroups as opportunistic, secondary analyses.
There were no genome-wide significant hits in the meta-analysis of adult females, but SNPs at a known neutrophil count locus (PSMD3, CSF3, MED24) (Okada et al. 2010) were associated with mtDNA CN at p~2e-07. It is established that cellular heterogeneity is related to mtDNA CN, (Pyle et al. 2010 ) and one of the strengths of this study is that we were able to control for this. This chr17 locus showed notable consistency of effect sizes across several study groups (UKBS males, UKBS females, ALSPAC neonates), corresponding to a ~0.08 reduction in SD units of log mtDNA CN per risk allele. However, there was notable (~50%) attenuation with adjustment for white cell proportions. Thus, a key finding of this study is the importance of undertaking GWAS of directly assayed mtDNA CN in sample sizes that are much larger, and that also have measures of white cell proportions. Ideally, these studies should be sufficiently large to enable exploration of any possible variation in nuclear genetic control of mtDNA copy number variation by sex and age.
Secondary analyses in ALSPAC children (6-9 years) and ALSPAC neonates, and UKBS males revealed three genome-wide significant hits: two intergenic loci in ALSPAC 6-9 year olds, and a region containing ABDH8 (abhydrolase-domain containing-8, a gene in head-tohead orientation with mitochondrial ribosomal protein L34, MRPL34) in ALSPAC neonates.
None of these associations were at all evident in the main meta-analysis of adult females.
Another mitochondrial ribosomal protein, MRPL37 has previously been found to associate with mtDNA CN, which (López et al. 2014 ) raises the possibility that the BABAM1-ANKLE1-ABHD8-MRPL34 locus might be a true signal, despite the lack of evidence of effect in our main analyses. Mitochondrial ribosomal proteins are encoded by nuclear DNA, synthesized on cytoplasmic ribosomes, then imported into mitochondria, where they facilitate the translation of mitochondrial mRNA, in conjunction with the two mitochondrially encoded rRNAs. (Sylvester et al. 2004 ) Whilst there are no candidate disorders for MRPL34, other diseases, such as Parkinson's disease (previously linked to reduced mtDNA CN (Pyle et al. 2016) ), are related to other mitochondrial ribosomal proteins. (Kenmochi et al. 2001; Sylvester et al. 2004; López et al. 2014) This locus also included an additional neighbouring gene, GTP Binding Protein 3 (Mitochondrial) (GTPBP3), associated with mtDNA CN at p~5e-07; rare mutations in this gene are known to cause a Leigh syndrome-like disorder. (Kopajtich et al. 2014 ) However, it is clear that independent replication will be needed in order to confirm these associations, since our current results are in a small sample from our secondary analyses only, and could be attributable to 'winner's curse'. (Xiao and Boehnke 2009) The identification of the cell-count associated locus (MED24) could suggest that some loci, such as the chr17 neutrophil count locus, may be related to mtDNA CN only via their association with cell count. It is noteworthy that the meta-analysis in which this locus was identified included ALSPAC mothers with DNA extracted from both white cells and whole blood: it is possible that combining individuals with DNA prepared from multiple sources could lead to preferential detection of loci associated with mtDNA CN predominantly via their association with cellular heterogeneity. When results from participants with more similar DNA sources are pooled, the power to detect loci associated with mtDNA CN independently of cell proportions may increase: we postulate that the BABAM1-ANKLE1-ABHD8-MRPL34
locus might be such a 'cell-count independent' locus (although as noted above, this needs further exploration). For loci in this latter category, controlling for cell proportions may improve the signal-to-noise ratio of observed associations, and failure to control for cellular proportions may act akin to measurement error. Future work should seek to assert whether associations of known neutrophil loci with mtDNA CN are entirely due to cell composition in DNA samples, or whether these loci are detected because mtDNA CN is causally related to leucocyte count. (Knez et al. 2016 ) Ideally, such studies would use directly assayed neutrophil data, as opposed to estimated cell counts. In addition, it might be useful to control associations for platelet count, since platelets are anucleate, but mitochondria-rich. (Urata et al. 2008; Hurtado-Roca et al. 2016) Beyond the possibility of true underlying genetic heterogeneity between our cohorts, several other technical factors may have limited their comparability. We believe that population stratification is unlikely to be a problem, as analyses controlled for principal components, and the correlation of MAFs for tops hits was high (see Supplementary Figure 9 ). Another technical difference between study groups is the DNA extraction method used. DNA extraction method has a considerable effect on mtDNA CN assay, (Guo et al. 2009 ) and similar qPCR assays, including that of telomere length. (Raschenberger et al. 2016) However, it is difficult to assess the extent to which DNA extraction method may have affected the performance of the mtDNA CN assay, since extraction method in ALSPAC was also related to age at DNA sampling, and it is possible that the genetic regulation of mtDNA CN varies across the life course.
When we combined all our study groups and looked at whether two hits from a previous in silico GWAS were replicated, we found some evidence for one (a SNP in mitochondrial transcription factor A (TFAM), but not the other (CDK6). (Cai et al. 2015) Despite the comparable sample sizes between our (N=11253) and the previous in silico (N=10442 discovery and N=1753 replication) analyses, we observed a considerably smaller effect size for the TFAM hit (~1/7 the size of the replication effect from the previous study, despite partial overlap in participants). We postulate that this might flag an important limitation in our work; namely that of measurement error. If a substantial component of our assayed mtDNA CNs includes non-differential measurement error, we would expect to see attenuation of effect sizes in our results. This is possible in qPCR assays: indeed, although we demonstrated correlations in relative mtDNA CNs in a validation analysis, we saw some suggestion of non-linearity. Whilst our attempted replication of the previous in silico GWAS hit had 100% power to detect effect sizes of 0.338 SD units (for a SNP with a MAF of 0.169, i.e. the TFAM SNP), this power calculation will be overoptimistic if our mtDNA CN assays are affected by measurement error. Therefore, we might suggest that in silico measurement of mtDNA CN may have advantages over the directly assayed method in this instance.
In conclusion, we confirm an association of TFAM with mtDNA CN, and after performing a range of hypothesis-generating GWAS in diverse study groups, we present several putative regulators of mtDNA CN, that will require further follow-up. However, we generally observed poor concordance across study groups. Overall, our main conclusion is that here we find no strong evidence to support our primary hypothesis of common loci regulating mtDNA CN in the study groups used here. We assess and discuss the possible implications of cellular heterogeneity on our results, and present the directly assayed mtDNA CN assay as another example of a qPCR assay that may be subject to measurement error. These findings should be considered as possible power-limiting factors in GWAS studying the genomic regulation of mtDNA CN. Nonetheless we believe that to fully understand nuclear genomic control of mtDNA CN variation, it is necessary to conduct GWAS of directly assayed mtDNA CN. Thus, our work (the largest GWAS to date) makes an important contribution in terms of future requirements to gain this knowledge, which is necessary for fuller understanding of the biology and potential clinical impact of subtle variation in mtDNA CN.
Figure 1 Manhattan (left) / QQ plots (right) for ALSPAC (all Mothers) and UKBS (females), and random-effects meta-analysis of both cohorts.
Top row=ALSPAC, Middle row=UKBS Females, Bottom row=Meta-analysis (randomeffects). λ =0.995 and 1.011 for ALSPAC (all Mothers) and UKBS Females respectively, and meta-analyses are corrected for these lambdas. 'Minimally-adjusted' refers to the fact that these results are from the analysis that did not adjust for cell proportions.
Figure 2 Manhattan (left) / QQ plots (right) for ALSPAC (white cell Mothers) and random-effects meta-analysis of both cohorts
Top row=ALSPAC, Bottom row=Meta-analysis (random-effects). λ =0.992 and 1.011 for ALSPAC (white cell Mothers) and UKBS females (see other plot), and meta-analyses are corrected for these lambdas. 'Minimally-adjusted' refers to the fact that these results are from the analysis that did not adjust for cell proportions.
Figure 3
Regional association plots (created with LocusZoom) of loci presented in the meta-analyses ( Table 2) .
Panels A-B are of loci identified in the meta-analysis of all ALSPAC mothers and UKBS females; panels C is of the one locus identified after restriction of the meta-analysis to ALSPAC mothers with DNA extracted from white cells, only. The lead SNP is annotated in purple, with other SNPs colour coded according to values of LD. P-value and recombination level are shown on the left and right y axes. A schematic of the region, along with coordinates and annotations (if any) is shown at the bottom of each plot. See also SNPs for two loci identified in a GWAS of in silico estimated mtDNA CN were extracted from each of the study groups in this cohort (NB: a smaller subset of 2833 mothers were used, since there were mother-child duos present between the original study group of 5461 and the two groups of ALSPAC children) Total N=11253 SNP=rsID; Gene=gene name; Group=study group, Beta=effect size; LCI/UCI=95% confidence interval (lower, then upper bound), P=p value, and I2=I 2 metric for heterogeneity. Meta-analyses were by random-effects, and are shown as black diamonds. For reference, the ALSPAC estimate from Cai et al. (2015) is shown for This replication group included ALSPAC 6-9 year olds (with mtDNA CN assayed from sequence data). Betas had to be harmonised, as those in Cai et al. [2015] w SD change in mtDNA CN per SD increase in genotype. SD of genotype was estimated from allele frequencies provided for the cohort by Cai et al. [2015] given as rs445 and 0.169 for rs11006126 (in the supplement of this paper). SDs were then calculated as sqrt(2*(1-MAF)*MAF) (evaluating to 0.53 and 0.67 for rs11006126 respectively). Betas and standard errors were then transformed from those given in Table 1 
